05 August 2026
05 August 2026
With several narcolepsy treatments advancing, the race for market leadership remains open.
Fuelled by blockbusters such as Eliquis, Pfizer is cementing its post-Covid revenue legacy.
This funding round will set Mironid up until the generation of initial clinical data, the company’s CEO says.
Asymchem Group will contribute $156m while Hillhouse Qirui will invest nearly $26m.
Chugai scientists will use Biomni Lab to consolidate diverse biomedical resources in a single digital workspace.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
